glp 1 hub podcast The Truth About GLP-1s: What No One Tells You with Ana Reisdorf GLP-1 Hub: Support, Community, and
Description
An uncertain future
doi: 10.2337/db14-0100 41 YanayOBaileyALKernanKZimmermanJJOsborneWR
In the landmark study for semaglutide, participants were randomized to semaglutide or placebo plus lifestyle interventions
Study tracks weight regain after stopping medication The new study, led by researchers at the University of Oxford and published in The BMJ, reviewed 37 existing clinical trials involving 9,341 participants who had taken weight-loss medications
But digestive side effects like diarrhea and vomiting can cause additional losses through the GI tract
doi: 10.1016/j.cmet.2009.08.001
